Semnur Pharmaceuticals, Inc. completed its merger with Denali Capital Acquisition Corp. on September 22, 2025, converting all Denali shares into New Semnur shares and establishing a new stock trading under the symbol 'SMNR'. This business combination involved a significant debt exchange, resulting in New Semnur holding over $54 million in previously owed debt converted to equity.